Pregledni rad
Paliperidone
Trpimir Glavina
Puni tekst: hrvatski pdf 79 Kb
str. 97-101
preuzimanja: 129
citiraj
APA 6th Edition
Glavina, T. (2023). Paliperidone. Medicus, 32 (1. Psihoze), 97-97. Preuzeto s https://hrcak.srce.hr/index.php/308623
MLA 8th Edition
Glavina, Trpimir. "Paliperidone." Medicus, vol. 32, br. 1. Psihoze, 2023, str. 97-97. https://hrcak.srce.hr/index.php/308623. Citirano 22.05.2024.
Chicago 17th Edition
Glavina, Trpimir. "Paliperidone." Medicus 32, br. 1. Psihoze (2023): 97-97. https://hrcak.srce.hr/index.php/308623
Harvard
Glavina, T. (2023). 'Paliperidone', Medicus, 32(1. Psihoze), str. 97-97. Preuzeto s: https://hrcak.srce.hr/index.php/308623 (Datum pristupa: 22.05.2024.)
Vancouver
Glavina T. Paliperidone. Medicus [Internet]. 2023 [pristupljeno 22.05.2024.];32(1. Psihoze):97-97. Dostupno na: https://hrcak.srce.hr/index.php/308623
IEEE
T. Glavina, "Paliperidone", Medicus, vol.32, br. 1. Psihoze, str. 97-97, 2023. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/308623. [Citirano: 22.05.2024.]
Puni tekst: engleski pdf 79 Kb
str. 97-97
preuzimanja: 90
citiraj
APA 6th Edition
Glavina, T. (2023). Paliperidone. Medicus, 32 (1. Psihoze), 97-97. Preuzeto s https://hrcak.srce.hr/index.php/308623
MLA 8th Edition
Glavina, Trpimir. "Paliperidone." Medicus, vol. 32, br. 1. Psihoze, 2023, str. 97-97. https://hrcak.srce.hr/index.php/308623. Citirano 22.05.2024.
Chicago 17th Edition
Glavina, Trpimir. "Paliperidone." Medicus 32, br. 1. Psihoze (2023): 97-97. https://hrcak.srce.hr/index.php/308623
Harvard
Glavina, T. (2023). 'Paliperidone', Medicus, 32(1. Psihoze), str. 97-97. Preuzeto s: https://hrcak.srce.hr/index.php/308623 (Datum pristupa: 22.05.2024.)
Vancouver
Glavina T. Paliperidone. Medicus [Internet]. 2023 [pristupljeno 22.05.2024.];32(1. Psihoze):97-97. Dostupno na: https://hrcak.srce.hr/index.php/308623
IEEE
T. Glavina, "Paliperidone", Medicus, vol.32, br. 1. Psihoze, str. 97-97, 2023. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/308623. [Citirano: 22.05.2024.]
Sažetak
Paliperidone is a second-generation antipsychotic, long-acting oral drug prescribed in a single daily dose, and a metabolite of risperidone. It is a strong antagonist of serotonin 5-HT2 and dopamine D2 receptors, and acts as a H1 histamine and alpha-1 blocker, and to a lesser extent alpha-2 adrenergic receptor. It is registered as treatment for schizophrenia and schizoaffective disorder for patients 15+ years of age. Paliperidone palmitate is a long-acting antipsychotic administered intramuscularly in different doses prescribed on a monthly, three-month, and six-month scale, after stabilization of the clinical picture with oral therapy of paliperidone or risperidone. It is registered as treatment for schizophrenia and schizoaffective disorder in adults aged 18 to 65.
Ključne riječi
paliperidone; paliperidone palmitate
Hrčak ID:
308623
URI
https://hrcak.srce.hr/308623
Datum izdavanja:
9.10.2023.
Podaci na drugim jezicima:
hrvatski
Posjeta: 343
*